Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price objective upped by HC Wainwright from $18.00 to $20.00 in a research note issued to investors on Friday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. TVTX has been the topic of several other reports. Piper Sandler decreased their price target on […]
E Fund Management Co. Ltd. increased its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 44.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,794 shares of the company’s stock after purchasing an additional 8,262 shares during […]
Operator: Good day, and welcome to the Travere Therapeutics Third Quarter 2023 Financial Results and Corporate Update Conference Call. Today s conference call is being recorded.
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) shares were up 4% during trading on Monday . The stock traded as high as $7.13 and last traded at $7.07. Approximately 115,876 shares were traded during trading, a decline of 92% from the average daily volume of 1,423,847 shares. The stock had previously closed at $6.80. […]
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target lowered by Piper Sandler from $19.00 to $10.00 in a research note released on Wednesday, Benzinga reports. The firm currently has a neutral rating on the stock. TVTX has been the subject of several other research reports. JPMorgan Chase & Co. started coverage on Travere […]